Latham & Watkins Advises Osler Diagnostics on Its US$85 Million Series C

Osler is a medical diagnostic company that has developed the Osler Origin – a portable diagnostic capable of performing a wide range of testing, with high-performance, in a rapid, low-cost, and easy-to-use manner. The Osler Origin will offer a wide portfolio of diagnostic tests and serve all major healthcare settings, globally.

The round included investment from a strategic investor, M&G Investments, and existing investors, including Oxford Science Enterprises, Braavos Investment Advisers, and Lansdowne Partners.

This investment will support Osler in advancing its Osler Origin product through regulatory activities, and towards market launch.

The Latham team was led by London corporate partner Robbie McLaren, with associates Aaron Bassett, Daria Les, Samantha Si, and Noreen Hesse.